CAS 128517-07-7
:(1S,4Z,7S,10S,11E,20R)-4-etilideno-7,20-dipropan-2-il-9-oxa-15,16-ditia-3,6,18,21-tetrazabiciclo[8.7.6]tricos-11-eno-2,5,8,19,22-pentona
Descrição:
A substância química com o nome "(1S,4Z,7S,10S,11E,20R)-4-etilideno-7,20-dipropan-2-il-9-oxa-15,16-ditia-3,6,18,21-tetrazabiciclo[8.7.6]tricos-11-eno-2,5,8,19,22-pentona" e número CAS "128517-07-7" é um composto orgânico complexo caracterizado por sua estrutura bicíclica única, que incorpora múltiplos grupos funcionais, incluindo moieties oxo e thia. A estereoquímica indicada pelas designações (S) e (Z) sugere arranjos espaciais específicos de átomos, que podem influenciar significativamente a reatividade e interações do composto. A presença de múltiplos grupos alquilo, como etilideno e dipropan-2-il, contribui para suas características hidrofóbicas, enquanto a estrutura bicíclica pode conferir rigidez à molécula. Este composto provavelmente exibirá propriedades químicas interessantes, incluindo potencial atividade biológica, devido à sua estrutura intrincada. Suas aplicações podem abranger vários campos, incluindo farmacêuticos e ciência dos materiais, embora os usos específicos dependam de mais pesquisas sobre suas propriedades e comportamento em diferentes ambientes.
Fórmula:C24H36N4O6S2
InChI:InChI=1/C24H36N4O6S2/c1-6-16-21(30)28-20(14(4)5)24(33)34-15-9-7-8-10-35-36-12-17(22(31)25-16)26-23(32)19(13(2)3)27-18(29)11-15/h6-7,9,13-15,17,19-20H,8,10-12H2,1-5H3,(H,25,31)(H,26,32)(H,27,29)(H,28,30)/b9-7+,16-6-/t15-,17+,19+,20-/m0/s1
Sinónimos:- Fr 901228
- Romidepsin
- (1R,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
9 produtos.
Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl], cyclic (3→5)-disulfide
CAS:Fórmula:C24H36N4O6S2Pureza:98%Cor e Forma:SolidPeso molecular:540.6958Ref: IN-DA000Y5C
1gA consultar1mg174,00€5mg194,00€10mg289,00€50mg502,00€100mgA consultar250mgA consultar500mgA consultarRomidepsin
CAS:Romidepsin (NSC-630176), an IV histone deacetylase inhibitor, treats refractory cutaneous/peripheral T-cell lymphomas.Fórmula:C24H36N4O6S2Pureza:99.4% - 99.94%Cor e Forma:SolidPeso molecular:540.7Romidepsin
CAS:Produto Controlado<p>Applications Romidepsin is a histone deacetylase inhibitor that can alter chromatin structure and gene transcription leading to multiple changes in cellular protein production. This may result in cell cycle arrest and tumor growth inhibition. Romidepsin has shown anti-proliferative activity in vitro against multiple mouse and human tumor cell lines and in vivo in human tumor xenograft models. Romidepsin can be administered with a second agent, such as a cytotoxic agent, a steroidal agent, a proteasome inhibitor, or a kinase inhibitor.<br>References Ueda, H., et al.: J. Antibiot., 47, 301 (1994), Weidle, U., et al.: Anticancer Res., 20, 1471 (2000), Kitazono, M., et al.: Cancer Res., 61, 6328 (2001), Sandor, V., et al.: Clin. Cancer Res., 8, 718 (2002),<br></p>Fórmula:C24H36N4O6S2Cor e Forma:White To Off-WhitePeso molecular:540.70Romidepsin
CAS:<p>Natural anti-cancer agent; inhibitor of histone deacetylases</p>Fórmula:C24H36N4O6S2Pureza:Min. 95 Area-%Cor e Forma:White PowderPeso molecular:540.7 g/molRomidepsin - Bio-X ™
CAS:This product is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.Fórmula:C24H36N4O6S2Pureza:Min. 95%Cor e Forma:PowderPeso molecular:540.7 g/molRomidepsin-d8
CAS:Produto Controlado<p>Applications Labelled Romidepsin (R425060). Romidepsin is a histone deacetylase inhibitor that can alter chromatin structure and gene transcription leading to multiple changes in cellular protein production. This may result in cell cycle arrest and tumor growth inhibition. Romidepsin has shown anti-proliferative activity in vitro against multiple mouse and human tumor cell lines and in vivo in human tumor xenograft models. Romidepsin can be administered with a second agent, such as a cytotoxic agent, a steroidal agent, a proteasome inhibitor, or a kinase inhibitor.<br>References Ueda, H., et al.: J. Antibiot., 47, 301 (1994), Weidle, U., et al.: Anticancer Res., 20, 1471 (2000), Kitazono, M., et al.: Cancer Res., 61, 6328 (2001), Sandor, V., et al.: Clin. Cancer Res., 8, 718 (2002),<br></p>Fórmula:C24D8H28N4O6S2Cor e Forma:NeatPeso molecular:548.745






